BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang H, Cho J, Buxbaum J. Update on the Prevention of Post-ERCP Pancreatitis. Curr Treat Options Gastroenterol. 2018;16:428-440. [PMID: 30334143 DOI: 10.1007/s11938-018-0194-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Lyu Y, Wang B, Cheng Y, Xu Y, Du W. Comparative Efficacy of 9 Major Drugs for Postendoscopic Retrograde Cholangiopancreatography Pancreatitis: A Network Meta-Analysis. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 2019;29:426-32. [DOI: 10.1097/sle.0000000000000707] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
2 Rana SS. High-dose NSAIDs and pancreatitis after ERCP: more is not always better. Lancet Gastroenterol Hepatol 2020;5:95-7. [PMID: 31780276 DOI: 10.1016/S2468-1253(19)30359-0] [Reference Citation Analysis]
3 Barreto SG, Habtezion A, Gukovskaya A, Lugea A, Jeon C, Yadav D, Hegyi P, Venglovecz V, Sutton R, Pandol SJ. Critical thresholds: key to unlocking the door to the prevention and specific treatments for acute pancreatitis. Gut 2021;70:194-203. [PMID: 32973069 DOI: 10.1136/gutjnl-2020-322163] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
4 Pekgöz M. Post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review for prevention and treatment. World J Gastroenterol 2019; 25(29): 4019-4042 [PMID: 31413535 DOI: 10.3748/wjg.v25.i29.4019] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 3] [Article Influence: 3.3] [Reference Citation Analysis]
5 Cheng C, Tang K, Cheng S, Fang H, Shiue S, Suk F, Lien G, Wu M. Comparison of endoscopic papillary large‐balloon dilatation with endoscopic sphincterotomy in clearing large common bile duct stones: A systematic review and meta‐analysis of randomized controlled trials. Adv in Digestive Medicine. [DOI: 10.1002/aid2.13295] [Reference Citation Analysis]
6 Nawaz MH, Sarwar S, Nadeem MA. Post-ERCP Pancreatitis: Risk factors and role of NSAIDs in primary prophylaxis. Pak J Med Sci 2020;36:426-31. [PMID: 32292447 DOI: 10.12669/pjms.36.3.1804] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wu ZX, Wang GL, Qiu P, Gong M, Li X, Wen JB. Selective indications of indomethacin and somatostatin, alone or in combination, and their preventive effects in patients at high risk for post-ERCP pancreatitis. Shijie Huaren Xiaohua Zazhi 2021; 29(21): 1222-1229 [DOI: 10.11569/wcjd.v29.i21.1222] [Reference Citation Analysis]